\n \n \n “. concat(self. i18n. t(‘search. voice. recognition_retry’), “\n
BOSTON, May 18, 2022 /PRNewswire/ — Valo Health, Inc. (“Valo”), the generation company whose goal is to transform human-centered knowledge and synthetic intelligence from the drug discovery and progression process, announced that its CEO and founder, David Berry, will be presented at UBS Global Healthcare 2022 on May 24 at 10:00 a. m. m. , Eastern Time, in the Winslow Assembly Hall of the Lotte New York Palace.
About Valo Santé
Valo Health, Inc. (“Valo”) is a generation company created to reshape the drug discovery and progression process using human-centered knowledge and synthetic intelligence-based calculations. As a local digital enterprise, Valo aims to fully integrate human-centered knowledge throughout the drug progression lifecycle into a single unified architecture, accelerating the discovery and progression of life-changing drugs while reducing costs, time, and failure rates. The company’s Opal Computational Platform™ is a built-in set of features designed to turn knowledge into valuable insights that can drive discoveries and enable Valo to advance a robust portfolio of systems in cardiovascular, metabolic, renal, oncological and neurodegenerative diseases. Founded through Flagship Pioneering and headquartered in Boston, MA, Valo also has offices in Lexington, MA, San Francisco. , CA, Princeton, NJ and Branford, CT. For more information, visit www. valohealth. com.
Contacts: Investors: Graeme Bell, Director financiergbell@valohealth. com
Media: Jennifer Hanley, Vice President of communications d’entreprisejhanley@valohealth. com
View Content: https://www. prnewswire. com/news-releases/valo-health-to-present-at-ubs-global-healthcare-conference-2022-301550003. html
SOURCEValo Health LLC